Nonionic surfactant excipients (NISEs) are commonly added
to biologics
formulations to mitigate the effects of stress incurred by the active
biotherapeutic during manufacturing, transport, and storage. During
manufacturing, NISEs are added by dilution of a stock solution directly
into a protein formulation, and their accurate addition is critical
in maintaining the quality and integrity of the drug product and thus
ensuring patient safety. This is especially true for the common NISEs,
polysorbates 20 and 80 (PS20 and PS80, respectively) and poloxamer
188 (P188). With the increasing diversity of biologic modalities within
modern pharmaceutical pipelines, there is thus a critical need to
develop and deploy convenient and user-accessible analytical techniques
that can rapidly and reliably quantify these NISEs under biopharmaceutically
relevant conditions. We thus pursued 60 MHz benchtop quantitative
NMR (qNMR) as a nondestructive and user-friendly analytical technique
for the quantification of PS20, PS80, and P188 under such conditions.
We demonstrated the ability of benchtop qNMR (1) to quantify simulated
PS20, PS80, and P188 stock solutions representative of those used
during the drug substance (DS) formulation step in biomanufacturing
and (2) to quantify these NISEs at and below their target concentrations
(≤0.025% w/v) directly in biologics formulations containing
histidine, sucrose, and one of three biotherapeutic modalities (monoclonal
antibody, antibody-drug conjugate, and Fc-fusion protein). Our results
demonstrate that benchtop qNMR offers a fit-for-purpose, reliable,
user-friendly, and green analytical route by which NISE of interest
to the biopharmaceutical industry may be readily and reliably quantified.
We conclude that benchtop qNMR has the potential to be applied to
other excipient formulation components in the presence of various
biological modalities as well as the potential for routine integration
within analytical and QC laboratories across pharmaceutical development
and manufacturing sites.